96 Best Glioma Doctors Worldwide

Dr. Murat Yaman is a plastic and reconstructive surgeon at Lokman Hekim Istanbul Hospital. He has performed over 1,500 rhinoplasties and 1,500 breast enlargements. Dr. Yaman also completed 500 facelifts and 1,000 liposuction procedures using VASER technology. He works at a JCI-accredited facility that treats 10,000+ patients annually.

• Specializes in tummy tucks, body contouring, and facial feminization surgery.
• Treats 500–600 patients each year for cosmetic and reconstructive needs.
• Member of the Turkish Society of Reconstructive, Aesthetic, and Plastic Surgery.
• Member of the Association of Emergency Hand and Microsurgery.

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Gerardo Conesa Bertran directs the Institute of Neurosurgery and Neurobiology at Teknon Medical Centre. He is a specialist in brain stem surgery and operations in highly functional brain areas. Dr. Conesa performs complex procedures for brain tumors, epilepsy, and Parkinson's disease. He holds a medical degree and doctorate with honors from the University of Barcelona.

• Completed a five-year training cycle with the European Association of Neurosurgical Societies.
• Former Ambassador for Spain to the Walter Dandy Neurosurgical Society.
• Served as the Director of Neurosurgery at Hospital del Mar for over ten years.
• Develops augmented reality platforms for planning and performing complex brain surgeries.

Dr. Ertugrul Pinar is a neurosurgeon at Hisar Hospital Intercontinental in Istanbul. He treats adult and pediatric patients with complex brain and spine diseases. Dr. Pinar focuses on brain tumors, vascular aneurysms, and skull base pathologies. He works at a JCI-accredited hospital that serves over 500,000 patients annually.

• Performs specialized procedures including transnasal tumor resection and brain aneurysm repair.
• Treats a wide range of conditions like pituitary adenomas and arteriovenous malformations.
• Expertise covers both surgical oncology and reconstructive spine surgery for herniated disks.
• Provides care for pediatric neurosurgical cases including hydrocephalus and shunt surgeries.

Dr. Javier Herrero Jover is a pioneer in 3D surgical planning, bringing 46 years of expertise to Centro Médico Teknon.

• Founder of Alma IT Systems for virtual surgical planning
• Author of 150+ publications and speaker at 350+ congresses
• Former President of CARS, leading global surgical tech congress
• Specializes in facial rejuvenation and complex reconstructions

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Dr. Bartolome Oliver is a pioneer in minimally invasive neurosurgery, performing over 900 brain tumor treatments with advanced techniques.

• 50 years of experience in complex brain tumor surgeries
• Director of the Brain Tumor Center at Centro Médico Teknon
• Specializes in fluorescence-guided surgery for precise tumor removal
• President of the European Skull Base Society
• Offers online consultations for remote second opinions

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Dr. Luis Madero is the Head of Pediatric Hemato-Oncology at Quironsalud Madrid University Hospital. He specializes in treating complex blood disorders and performing bone marrow transplants. Dr. Madero serves as a Professor of Pediatrics at the Autonomous University of Madrid. He works at Quironsalud Madrid, which Newsweek ranked among the World's Best Hospitals.

• Edited 14 books and contributed to 75 book chapters on pediatric oncology.
• Treats leukemia, lymphoma, multiple myeloma, and sickle cell disease.
• Member of the Spanish Association of Pediatric Hematology and Oncology.
• Former Head of Oncology at the Sanitas Group and Nino Jesus Hospital.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Prof. Sezer Sağlam specializes in medical oncology with a focus on glioma treatment at Gayrettepe Florence Nightingale Hospital.

• Professor in Medical Oncology since 2016
• Fellowship-trained at Istanbul University
• Member of ESMO, ASCO, and Turkish Medical Oncology Association

Dr. Zvi Cohen is the Director of the Neurosurgery Department at Sheba Medical Center. He was recently recognized in Forbes Israel’s Best Doctors list for 2025. Dr. Cohen specializes in treating complex brain, pituitary, and spinal cord tumors. He founded the brain tumor tissue bank at Sheba to support oncological research. Dr. Cohen is board-certified in neurosurgery and leads clinical trials for malignant brain tumors.

• Completed fellowships in neurosurgical oncology at MD Anderson and neuroradiology at Beth Israel.
• Expert in intraoperative MRI, stereotactic biopsies, and image-guided resections.
• Performs radiosurgery and minimally invasive microsurgery for CNS tumors.
• Member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Professor Doctor Sefik Igdem specializes in advanced radiation oncology for brain tumors at Gayrettepe Florence Nightingale Hospital.

• Expert in Truebeam Stx and Halcyon technologies
• Subspecialty focus on head and neck cancers
• Professor at T.R Demiroğlu Bilim University
• Trained at Istanbul University Cerrahpaşa Faculty of Medicine

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Graupera developed a passive treatment for spinal cord gliomas without radiation therapy – a breakthrough in pediatric oncology. Heads the Hematology Oncology Department at Sant Joan De Déu.

• Trained at Memorial Sloan Kettering Cancer Center in pediatric oncology
• Over 70 published papers on malignant tumors in children
• Recipient of multiple prestigious awards including the Schweisguth Prize
• Scientific Director of Developmental Tumors Laboratory